IRIS
IRIS Home | Critical Effect Search Results
Searches using filters for organ/system affected are limited to effects (or tumor sites) used to derive the
RfD, RfC, oral slope factor, or inhalation unit risk.
Other effects associated with chemicals in the IRIS database that were not used as the basis for a toxicity value are not searchable with
organ/system filters. IRIS Advanced Search searches only final IRIS assessments; to look for information on draft assessments, see
Quick Check: Assessments in Development.
Search Filtered by: Critical Effect = "Endocrine"
Number of records: 29
| Chemical Name | CASRN | Exposure Route | Critical Effect | RfD/RfC | RfD/RfC Value |
|---|---|---|---|---|---|
| Apollo | 74115-24-5 | Oral | Liver effects; organ weight changes | RFD | 1.3 x 10 -2 mg/kg-day |
| Chlorine cyanide | 506-77-4 | Oral | Weight loss, thyroid effects, and myelin degeneration | RFD | 5 x 10 -2 mg/kg-day |
| Chlorodifluoromethane | 75-45-6 | Inhalation | Increased kidney, adrenal and pituitary weights | RFC | 5 x 10 1 mg/m3 |
| Cumene | 98-82-8 | Inhalation | Increased kidney weights in female rats and adrenal weights in male and female rats | RFC | 4 x 10 -1 mg/m3 |
| Cyanogen bromide | 506-68-3 | Oral | Weight loss, thyroid effects and myelin degeneration | RFD | 9 x 10 -2 mg/kg-day |
| Dacthal | 1861-32-1 | Oral | Effects on the lungs, liver, kidney, thyroid and thyroid hormones in males and females and eyes of females | RFD | 1 x 10 -2 mg/kg-day |
| 1,2-Dibromoethane | 106-93-4 | Oral | Testicular atrophy, liver peliosis, and adrenal cortical degeneration | RFD | 9 x 10 -3 mg/kg-day |
| Dodine | 2439-10-3 | Oral | Thyroid toxicity | RFD | 4 x 10 -3 mg/kg-day |
| Ethylene thiourea (ETU) | 96-45-7 | Oral | Increased incidence of thyroid hyperplasia | RFD | 8 x 10 -5 mg/kg-day |
| Glycidaldehyde | 765-34-4 | Oral | Weight gain retardation, enlarged adrenals, hydropic renal pelvis and hematopoietic effects | RFD | 4 x 10 -4 mg/kg-day |
| Hydrogen Cyanide and Cyanide Salts | Various | Inhalation | Thyroid enlargement and altered iodide uptake | RFC | 8 x 10 -4 mg/m3 |
| Maneb | 12427-38-2 | Oral | Increased thyroid weight | RFD | 5 x 10 -3 mg/kg-day |
| Mirex | 2385-85-5 | Oral | Liver cytomegaly, fatty metamorphosis, angiectasis; thyroid cystic follicles | RFD | 2 x 10 -4 mg/kg-day |
| Norflurazon | 27314-13-2 | Oral | Liver and thyroid effects | RFD | 4 x 10 -2 mg/kg-day |
| Oryzalin | 19044-88-3 | Oral | Increases in serum cholesterol, alkaline phosphatase, and relative liver and kidney weights, and decreases in alanine transaminase and adrenal weights | RFD | 5 x 10 -2 mg/kg-day |
| Perchlorate (ClO4) and Perchlorate Salts | 7790-98-9 | Oral | Radioactive iodide uptake inhibition (RAIU) in the thyroid | RFD | 7 x 10 -4 mg/kg-day |
| Perfluorobutanoic Acid (PFBA) | 375-22-4 | Oral | Decreased total T4 | RFD | 1 x 10 -2 mg/kg-day |
| Perfluorobutanoic Acid (PFBA) | 375-22-4 | Oral | Increased hepatocellular hypertrophy (Liver), Decreased total T4 (Thyroid) | RFD | 1 x 10 -3 mg/kg-day |
| Perfluorohexanoic Acid (PFHxA) | 307-24-4 | Oral | Decreased total T4 in adult male Harlan Sprague-Dawley rats | RFD | 1 x 10 -3 mg/kg-day |
| Savey | 78587-05-0 | Oral | Hypertrophy of adrenal cortex (both sexes) hematologic effects (males) | RFD | 2.5 x 10 -2 mg/kg-day |
| Silver cyanide | 506-64-9 | Oral | Weight loss, thyroid effects, and myelin degeneration | RFD | 1 x 10 -1 mg/kg-day |
| Terbacil | 5902-51-2 | Oral | Increase in thyroid/body weight ratio; slight increase in liver weights; elevated alkaline phosphatase | RFD | 1.3 x 10 -2 mg/kg-day |
| 2,3,7,8-Tetrachlorodibenzo-p-dioxin | 1746-01-6 | Oral | Decreased sperm count and motility in men exposed to TCDD as boys / Increased TSH in neonates | RFD | 7 x 10 -10 mg/kg-day |
| Thiophanate-methyl | 23564-05-8 | Oral | Decreased body weight, decreased spermatogenesis, and histological evidence of hyperthyroidism | RFD | 8 x 10 -2 mg/kg-day |
| 1,2,4-Trichlorobenzene | 120-82-1 | Oral | Increased adrenal weights; vacuolization of zona fasciculata in the cortex | RFD | 1 x 10 -2 mg/kg-day |
| 1,1,2-Trichloropropane | 598-77-6 | Oral | Mild lesions in liver, kidney and thyroid | RFD | 5 x 10 -3 mg/kg-day |
| Vinclozolin | 50471-44-8 | Oral | Organ weight changes (adrenal and kidney) | RFD | 2.5 x 10 -2 mg/kg-day |
| Zinc cyanide | 557-21-1 | Oral | Weight loss, thyroid effects, and myelin degeneration | RFD | 5 x 10 -2 mg/kg-day |
| Zineb | 12122-67-7 | Oral | Thyroid hyperplasia | RFD | 5 x 10 -2 mg/kg-day |